Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Prolymphocytic, B-Cell × Pharmacogenomic Variants × Clear all

Sponsor

Conditions

Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Histiocytosis, Langerhans-Cell 1 Hepatoblastoma 1 Glioma 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Ependymoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Adrenal Cortex Neoplasms 1

Interventions

fludarabine phosphate 2 Whole-Body Irradiation 2 Mycophenolic Acid 2 obinutuzumab 1 letermovir 1 carmustine, poliferprosan 20 drug combination 1 Tacrolimus 1 Stem Cell Transplantation 1 Peripheral Blood Stem Cell Transplantation 1 Melphalan 1 Hematopoietic Stem Cell Transplantation 1 Etoposide 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Carmustine 1 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡